Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Change in Cash (2016 - 2025)

Historic Change in Cash for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $46000.0.

  • International Stem Cell's Change in Cash rose 17058.82% to $46000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$341000.0, marking a year-over-year decrease of 17723.58%. This contributed to the annual value of -$358000.0 for FY2024, which is 14231.68% down from last year.
  • As of Q3 2025, International Stem Cell's Change in Cash stood at $46000.0, which was up 17058.82% from -$532000.0 recorded in Q2 2025.
  • Over the past 5 years, International Stem Cell's Change in Cash peaked at $439000.0 during Q2 2023, and registered a low of -$532000.0 during Q2 2025.
  • Moreover, its 5-year median value for Change in Cash was $48000.0 (2023), whereas its average is $14578.9.
  • Examining YoY changes over the last 5 years, International Stem Cell's Change in Cash showed a top increase of 20990.1% in 2025 and a maximum decrease of 45416.67% in 2025.
  • Quarter analysis of 5 years shows International Stem Cell's Change in Cash stood at -$334000.0 in 2021, then soared by 122.75% to $76000.0 in 2022, then soared by 107.89% to $158000.0 in 2023, then tumbled by 148.73% to -$77000.0 in 2024, then soared by 159.74% to $46000.0 in 2025.
  • Its Change in Cash was $46000.0 in Q3 2025, compared to -$532000.0 in Q2 2025 and $222000.0 in Q1 2025.